U.S. Markets closed

Digirad Corp (DRAD) Files 10-K for the Fiscal Year Ended on December 31, 2017

- By insider

Digirad Corp (DRAD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Digirad Corp develops nuclear technology for mobile cardiovascular imaging for various application. The company commercialized the first nuclear gamma camera and offers its products to doctors' offices and hospitals. Digirad Corp has a market cap of $41.124 million; its shares were traded at around $2.05 with and P/S ratio of 0.35. The dividend yield of Digirad Corp stocks is 10.49%.


For the last quarter Digirad Corp reported a revenue of $30.9 million, compared with the revenue of $31.13 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $118.3 million, a decrease of 5.7% from the previous year. For the last five years Digirad Corp had an average revenue growth rate of 22.6% a year.

The reported loss per diluted share was $1.79 for the year, compared with the earnings per share of $1.1 in the previous year. The Digirad Corp had an operating margin of -5.09%, compared with the operating margin of 2.46% a year before. The 10-year historical median operating margin of Digirad Corp is -1.88%. The profitability rank of the company is 5 (out of 10).

At the end of the fiscal year, Digirad Corp has the cash and cash equivalents of $1.88 million, compared with $2.20 million in the previous year. The long term debt was $19.5 million, compared with $16.1 million in the previous year. Digirad Corp has a financial strength rank of 4 (out of 10).

At the current stock price of $2.05, Digirad Corp is traded at 57.7% discount to its historical median P/S valuation band of $4.85. The P/S ratio of the stock is 0.35, while the historical median P/S ratio is 0.82. The stock lost 56.86% during the past 12 months.

For the complete 20-year historical financial data of DRAD, click here.

This article first appeared on GuruFocus.